Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY: DVA )

137.95 +1.89 (+1.39%)
Official Closing Price Updated: 7:00 PM EDT, Jul 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 698,409
Open 136.90
Bid (Size) 137.33 (1)
Ask (Size) 138.49 (1)
Prev. Close 136.06
Today's Range 134.48 - 138.89
52wk Range 71.51 - 147.93
Shares Outstanding 104,800,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Financial Crime Weekly: DaVita Agrees To Pay $34.5M For Kickbacks, Hospice Provider Doles Out $19.4M For False Claims
DaVita Inc., a kidney dialysis provider, will pay $34.5 million for allegedly paying kickbacks to competitors and doctors for patient referrals. 
Via Benzinga
2 Warren Buffett Stocks to Buy Hand Over Fist and 1 to Avoid
As the late Meatloaf once sang, "Two out of three ain't bad." 
Via The Motley Fool

Performance

YTD
+29.06%
+29.06%
1 Month
-2.43%
-2.43%
3 Month
+4.10%
+4.10%
6 Month
+31.85%
+31.85%
1 Year
+35.11%
+35.11%

More News

Read More
Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway
Via InvestorPlace
These Warren Buffett Stocks Are Trouncing the S&P 500 so Far This Year. Are They Still Buys?
Via The Motley Fool
Topics Stocks
Exposures US Equities
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
Via Benzinga
6 Analysts Assess DaVita: What You Need To Know
Via Benzinga
DaVita Inc. (NYSE: DVA) Making Surprising Moves in Tuesday Session
Via Investor Brand Network
Tandem Diabetes Catapults Above A Profit-Taking Zone, But DaVita Reverses, Nearly Triggering A Sell Signal
Via Investor's Business Daily
The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy?
Via InvestorPlace
DaVita (DVA) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026
Via InvestorPlace
Warren Buffett's 3 Best-Performing Stocks So Far in 2024: Are They Buys Now?
Via The Motley Fool
Ford, Nvidia Among Top S&P 500 Stocks Monday; Tesla Extends Losses
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
Via Investor's Business Daily
The Best Warren Buffett Stocks to Buy With $300 Right Now
Via The Motley Fool
3 Soaring, Highly-Ranked Value Stocks To Buy In April
Via Talk Markets
3 High-Dividend ETFs That Could Be Smart Investments Right Now
Via The Motley Fool
Topics Bonds ETFs
Exposures Debt Markets
Warren Buffett's Berkshire Hathaway Owns Over 25% of These 4 Companies (Hint: Apple Isn't One of Them)
Via The Motley Fool
3 No-Brainer Warren Buffett Stocks to Buy Right Now
Via The Motley Fool
Why Are Dialysis Provider Stocks Trading Higher On Tuesday?
Via Benzinga
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News
Via Investor's Business Daily
3 Cheap Stocks to Buy Now for Fast Gains
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.